Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

被引：99
|
作者：
Ghaffari, Maryam [1 ,2 ,3 ]
Dehghan, Gholamreza [2 ]
Baradaran, Behzad [4 ]
Zarebkohan, Amir [5 ]
Mansoori, Behzad [4 ]
Soleymani, Jafar [6 ]
Dolatabadi, Jafar Ezzati Nazhad [7 ]
Hamblin, Michael R. [8 ,9 ,10 ]
机构：
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[7] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[8] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA
[10] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa
来源：
COLLOIDS AND SURFACES B-BIOINTERFACES | 2020年 / 188卷
关键词：
Curcumin; Bcl-2; siRNA; PAMAM dendrimer; Co-delivery; HeLa cancer cells; Nanoparticles; DENDROSOMAL CURCUMIN; ANTICANCER ACTIVITY; INDUCE APOPTOSIS; BREAST-CANCER; IN-VITRO; NANOPARTICLES; DRUG; DOXORUBICIN; CISPLATIN; PATHWAYS;
D O I：
10.1016/j.colsurfb.2019.110762
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Co-delivery of therapeutic agents and small interfering RNA (siRNA) can be achieved by a suitable nanovehicle. In this work, the solubility and bioavailability of curcumin (Cur) were enhanced by entrapment in a poly-amidoamine (PAMAM) dendrimer, and a polyplex was formed by grafting Bcl-2 siRNA onto the surface amine groups to produce PAMAM-Cur/Bcl-2 siRNA nanoparticles (NPs). The synthesized polyplex NPs had a particle size of similar to 180 nm, and high Cur loading content of similar to 82 wt%. Moreover, the PAMAM-Cur/Bcl-2 siRNA NPs showed more effective cellular uptake, and higher inhibition of tumor cell proliferation compared to PAMAM-Cur nanoformulation and free Cur, due to the combined effect of co-delivery of Cur and Bcl-2 siRNA. The newly described PAMAM-Cur/Bcl-2 siRNA polyplex NPs could be a promising co-delivery nanovehicle.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells
    Alinejad, Vahideh
    Somi, Mohammad Hossein
    Baradaran, Behzad
    Akbarzadeh, Parvin
    Atyabi, Fatemeh
    Kazerooni, Hanif
    Kafil, Hosein Samadi
    Maleki, Leili Aghebati
    Mansouri, Homayoon Siah
    Yousefi, Mehdi
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 229 - 240
  • [42] Co-delivery of miRNA-15a and miRNA-16–1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells
    Maedeh Ghaffari
    Seyed Mehdi Kalantar
    Mahdie Hemati
    Ali Dehghani Firoozabadi
    Amir Asri
    Ali Shams
    Sina Jafari Ghalekohneh
    Fateme Haghiralsadat
    Biotechnology Letters, 2021, 43 : 981 - 994
  • [43] Co-delivery of miRNA-15a and miRNA-16-1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells
    Ghaffari, Maedeh
    Kalantar, Seyed Mehdi
    Hemati, Mahdie
    Dehghani Firoozabadi, Ali
    Asri, Amir
    Shams, Ali
    Jafari Ghalekohneh, Sina
    Haghiralsadat, Fateme
    BIOTECHNOLOGY LETTERS, 2021, 43 (05) : 981 - 994
  • [44] Asymmetric siRNA targeting the bcl-2 gene inhibits the proliferation of cancer cells in vitro and in vivo
    Yin, Yan
    Chen, Xu
    Zhang, Chang-Dong
    Liu, Pei-Feng
    Duan, You-Rong
    Fan, Yan-Rong
    Wu, Zhi-Wei
    Fu, Geng-Feng
    Wang, Jian-Jun
    Xu, Gen-Xing
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (01) : 253 - 260
  • [45] Exploiting the Warburg Effect: Co-Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy
    Zhou, Wenhui
    Ma, Xiaodong
    Xiao, Jianpeng
    He, Xiaohui
    Liu, Chang
    Xu, Xiaoyu
    Viitala, Tapani
    Feng, Jing
    Zhang, Hongbo
    SMALL SCIENCE, 2024, 4 (03):
  • [46] Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells
    Zolbanin, Naime Majidi
    Jafari, Reza
    Majidi, Jafar
    Atyabi, Fatemeh
    Yousefi, Mehdi
    Jadidi-Niaragh, Farhad
    Aghebati-Maleki, Leili
    Shanehbandi, Dariush
    Zangbar, Mohammad-Sadegh Soltani
    Nayebi, Alireza Mohajjel
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (03) : 383 - 393
  • [47] Cationic liposomes for co-delivery of paclitaxel and anti-Plk1 siRNA to achieve enhanced efficacy in breast cancer
    Bulbake, Upendra
    Kommineni, Nagavendra
    Bryszewska, Maria
    Ionov, Maksim
    Khan, Wahid
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 48 : 253 - 265
  • [48] A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells
    Baek, Jong-Suep
    Cho, Cheong-Weon
    ONCOTARGET, 2017, 8 (18) : 30369 - 30382
  • [49] Multifunctional block copolymer nanocarriers for co-delivery of silver nanoparticles and curcumin: Synthesis and enhanced efficacy against tumor cells
    Petrov, Petar D.
    Yoncheva, Krassimira
    Gancheva, Valeria
    Konstantinov, Spiro
    Trzebicka, Barbara
    EUROPEAN POLYMER JOURNAL, 2016, 81 : 24 - 33
  • [50] Study of Bcl-2 siRNA Enhancement of Sensitivity of HL-60 Cells to All Trans Retinoic Acid
    Haiyan Hu Yuan Zhang Dongmei He Institute of Hematology
    Chinese Journal of Clinical Oncology, 2008, (02) : 118 - 121
12345